Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2021-08-11 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
UPDATE ON US REVIEW OF ROXADUSTAT
Foreign Filer Report
2021-08-11 English
Update on US review of roxadustat
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date (11 August 2021) and a brief update regarding a regulatory decision (FDA Complete Response Letter for roxadustat). It is a short, timely announcement about a specific corporate/regulatory event, not a comprehensive financial report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement distributed via RNS (London Stock Exchange's news service), and it doesn't fit perfectly into categories like Director's Dealing, Dividend Notice, or Earnings Release, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard market disclosure.
2021-08-11 English
FORXIGA APPROVED IN THE EU FOR CKD
Foreign Filer Report
2021-08-09 English
ENHERTU HEAD-TO-HEAD TRIAL MEETS PRIMARY ENDPOINT
Foreign Filer Report
2021-08-09 English
Forxiga approved in the EU for CKD
Earnings Release Classification · 99% confidence The document begins with 'RNS Number' and is dated August 9, 2021. It announces a significant regulatory/marketing event: the approval of the drug Forxiga in the EU for treating chronic kidney disease. This type of announcement, which details a specific corporate event (a regulatory approval) and is distributed via the RNS system (London Stock Exchange's news service), fits best under the general 'Regulatory Filings' category, as it is not a comprehensive financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). While it is a press release, RNS serves as the primary distribution channel for such non-standardized regulatory news that doesn't fit the other specific codes. Given the context of a major drug approval announcement distributed via RNS, 'RNS' is the most appropriate classification. Q3 2021
2021-08-09 English
Enhertu head-to-head trial meets primary endpoint
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the RNS service of the London Stock Exchange. The content details positive clinical trial results (DESTINY-Breast03) for the drug Enhertu, including efficacy endpoints (PFS) and safety profiles, and mentions plans for global regulatory submissions. This type of announcement, which communicates material, non-public information to the market promptly, fits the description of a general regulatory filing or announcement that doesn't fit a more specific category like an Earnings Release (ER) or a full Annual Report (10-K). Since it is a formal announcement distributed through the official regulatory news service (RNS), the most appropriate classification is Regulatory Filings (RNS). The document length is substantial (13,257 chars), but its primary function is the announcement itself, not the underlying detailed report.
2021-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.